![]() |
市場調查報告書
商品編碼
2128211
青光眼手術用醫療設備的市場規模、佔有率、成長、全球產業分析、區域趨勢及 2026-2034 年預測。Glaucoma Surgery Devices Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
隨著全球青光眼發生率持續上升,青光眼手術醫療設備的全球市場也呈現穩定成長態勢。青光眼是導致不可逆性失明的主要原因之一,當藥物或雷射治療無法有效控制眼壓時,手術介入便成為必要。該市場涵蓋青光眼引流植入、微創青光眼手術(MIGS)器械、雷射系統、濾過裝置以及各種旨在改善患者預後並減輕治療負擔的手術耗材。
2025年全球青光眼手術醫療設備市場規模為15.5億美元,預計將從2026年的16.4億美元成長至2034年的24.8億美元,預測期內複合年成長率(CAGR)為5.3%。北美市場在2025年佔據主導地位,市佔率達36.13%,這得益於其先進的醫療基礎設施、完善的保險報銷體係以及創新型青光眼治療技術的快速普及。
市場趨勢
植入式和先進雷射技術的發展
影響青光眼手術醫療設備市場的關鍵趨勢之一是植入式青光眼治療設備和新一代雷射技術的日益普及。製造商正致力於研發緩釋型前房植入,以減少患者對每日眼藥水的依賴,並提高長期治療順從性。
此外,雷射輔助青光眼手術正透過可視化導引系統不斷發展,從而提高手術的精確性和安全性。先進影像技術和微創手術方法的日益普及,使眼科醫師能夠在最大限度縮短患者恢復時間的同時,獲得更好的臨床療效。
市場促進因素
全球青光眼患者人數正在增加。
青光眼盛行率的不斷上升是推動市場成長的主要因素之一。由於人口老化、糖尿病發生率上升以及人們對該疾病的認知不斷提高,全球青光眼診斷率正在上升。
隨著越來越多的青光眼患者病情發展至中度至晚期,對青光眼手術的需求持續成長。微創青光眼手術(MIGS)日益受到青睞,進一步加速了醫療專業人員和病患對相關醫療設備的接受度。
市場限制因素
手術費用高昂
儘管需求強勁,青光眼手術的高昂費用仍然是一大限制因素。先進的微創青光眼手術需要專用植入、精密的手術器械和訓練有素的眼科醫師。
除了手術費用外,術後後續觀察、定期檢查以及再次手術的可能性都會增加治療總成本。這些因素會限制患者獲得治療的機會,尤其是在醫療費用支出較低的開發中國家。
市場機遇
過渡到微創青光眼手術(MIGS)
消費者對更安全、創傷更小的治療方法的需求日益成長,為市場創造了巨大的機會。微創青光眼手術(MIGS)相比傳統青光眼手術具有許多優勢,包括減輕患者的身體負擔、縮短恢復時間、減少併發症以及提高患者舒適度。
隨著外科醫生在使用 MIGS 設備方面累積經驗,他們的技能不斷提高,預計製造商將推出創新產品,進一步擴大 MIGS 在已開發和新興醫療保健市場中的應用。
市場挑戰
熟練眼科醫師短缺
影響市場擴張的主要挑戰之一是能夠進行先進青光眼手術的訓練有素的眼科醫生短缺。微創青光眼手術(MIGS)和其他現代手術技術都需要專門的訓練和專業技能。
許多新興經濟體仍然面臨眼科醫療專業人員短缺的問題,這限制了農村地區和醫療服務匱乏地區獲得先進青光眼治療的機會。儘管患者需求不斷成長,但人員短缺可能會減緩新手術技術的推廣應用。
區域分析
北美洲
北美仍然是最大的區域市場,預計到 2025 年將達到 5.6 億美元。該地區充分利用其優勢,包括慷慨的保險報銷制度、對創新技術的早期採用以及大量的青光眼手術。
預計到 2026 年,美國青光眼手術醫療設備市場規模將達到約 5.1 億美元,約佔全球銷售額的 31.1%。
歐洲
預計歐洲將穩定成長,到 2026 年將達到 4.8 億美元。這一成長得益於健全的青光眼篩檢計劃、先進的醫療保健系統以及遍布德國、英國和法國等國家的大量眼科醫生。
亞太地區
預計到 2026 年,亞太市場規模將達到 3.9 億美元。醫療保健投資的增加、人們對青光眼的認知不斷提高以及眼科醫療保健服務覆蓋範圍的擴大,正在推動中國、日本、印度和其他新興經濟體的市場成長。
拉丁美洲、中東和非洲
由於眼科醫療基礎設施的改善、對青光眼致盲的認知提高以及先進外科技術的逐步引入,預計這些地區將經歷逐步成長。
The global glaucoma surgery devices market is experiencing steady growth as the prevalence of glaucoma continues to rise worldwide. Glaucoma is one of the leading causes of irreversible blindness, and surgical intervention becomes necessary when medications and laser therapies fail to adequately control intraocular pressure (IOP). The market includes glaucoma drainage implants, minimally invasive glaucoma surgery (MIGS) devices, laser systems, filtration devices, and various surgical consumables designed to improve patient outcomes while reducing treatment burden.
The global glaucoma surgery devices market size was valued at USD 1.55 billion in 2025 and is projected to increase from USD 1.64 billion in 2026 to USD 2.48 billion by 2034, registering a CAGR of 5.3% during the forecast period. North America dominated the market with a 36.13% share in 2025, supported by advanced healthcare infrastructure, strong reimbursement systems, and rapid adoption of innovative glaucoma treatment technologies.
Market Trends
Growth of Implantable and Advanced Laser-Based Technologies
A major trend shaping the glaucoma surgery devices market is the increasing adoption of implantable glaucoma devices and next-generation laser technologies. Manufacturers are focusing on sustained-release intracameral implants that reduce dependence on daily eye drops and improve long-term treatment adherence.
Additionally, laser-assisted glaucoma surgery is evolving through visualization-guided systems that improve surgical precision and safety. The growing use of advanced imaging technologies and minimally invasive approaches is helping ophthalmologists achieve better clinical outcomes while minimizing patient recovery times.
Market Drivers
Rising Global Burden of Glaucoma
The increasing prevalence of glaucoma is one of the primary factors driving market growth. Aging populations, rising diabetes incidence, and improved disease awareness are leading to higher diagnosis rates worldwide.
As more patients progress to moderate and advanced stages of glaucoma, demand for surgical interventions continues to rise. The growing preference for minimally invasive glaucoma surgery (MIGS) procedures is further accelerating device adoption among healthcare providers and patients.
Market Restraints
High Cost of Surgical Procedures
Despite strong demand, the high cost associated with glaucoma surgeries remains a major restraint. Advanced MIGS procedures require specialized implants, sophisticated surgical tools, and highly trained ophthalmic surgeons.
In addition to procedural expenses, postoperative monitoring, follow-up visits, and potential repeat interventions increase overall treatment costs. These factors can limit patient access, especially in developing economies with lower healthcare spending.
Market Opportunities
Shift Toward Minimally Invasive Glaucoma Surgery (MIGS)
The growing preference for safer and less invasive treatment options is creating significant opportunities within the market. MIGS procedures offer several advantages compared to traditional glaucoma surgeries, including reduced surgical trauma, shorter recovery periods, fewer complications, and improved patient comfort.
As surgeons gain greater experience with MIGS devices and technology continues to improve, manufacturers are expected to introduce innovative products that further expand adoption across both developed and emerging healthcare markets.
Market Challenges
Shortage of Skilled Ophthalmic Surgeons
A key challenge affecting market expansion is the shortage of trained ophthalmologists capable of performing advanced glaucoma procedures. MIGS and other modern surgical techniques require specialized training and expertise.
Many emerging countries continue to face shortages of eye care professionals, limiting access to advanced glaucoma treatments in rural and underserved regions. This workforce gap may slow the adoption of new surgical technologies despite increasing patient demand.
Segment Analysis
By Device Type
The minimally invasive surgery devices segment dominated the market in 2025. The segment's growth is attributed to increasing surgeon preference for MIGS devices due to their superior safety profile, quicker recovery times, and effectiveness in treating mild-to-moderate primary open-angle glaucoma.
Meanwhile, the laser systems segment is projected to expand at a CAGR of 4.7% during the forecast period as advanced laser technologies gain wider clinical acceptance.
By Procedure Type
The minimally invasive surgery segment held the largest market share in 2025 and is expected to account for 39.5% of the market in 2026. MIGS procedures effectively bridge the treatment gap between medication-based therapy and traditional filtration surgeries.
The laser surgery segment is also anticipated to witness steady growth due to improvements in laser-guided treatment platforms.
By End User
The hospitals & ambulatory surgery centers (ASCs) segment dominated the market in 2025 and is projected to hold 66.4% market share in 2026. These facilities possess advanced surgical infrastructure, experienced ophthalmic surgeons, and specialized equipment required for glaucoma interventions.
Specialty eye clinics are expected to witness notable growth due to increasing patient preference for dedicated ophthalmology centers.
Regional Analysis
North America
North America remained the largest regional market, reaching USD 0.56 billion in 2025. The region benefits from strong reimbursement policies, early adoption of innovative technologies, and a high volume of glaucoma procedures.
The U.S. glaucoma surgery devices market is projected to reach approximately USD 0.51 billion in 2026, accounting for around 31.1% of global revenue.
Europe
Europe is expected to grow steadily, reaching USD 0.48 billion by 2026. Growth is supported by strong glaucoma screening programs, advanced healthcare systems, and a large base of ophthalmology specialists across countries such as Germany, the U.K., and France.
Asia Pacific
The Asia Pacific market is projected to reach USD 0.39 billion in 2026. Rising healthcare investments, increasing awareness about glaucoma, and expanding access to ophthalmic services are supporting market expansion across China, Japan, India, and other emerging economies.
Latin America and Middle East & Africa
These regions are expected to experience moderate growth due to improving eye care infrastructure, increasing awareness regarding glaucoma-related blindness, and gradual adoption of advanced surgical technologies.
Competitive Landscape
The glaucoma surgery devices market remains highly competitive, with major companies focusing on innovation, strategic acquisitions, and portfolio expansion. Leading players include:
Recent product launches, FDA approvals, acquisitions, and reimbursement advancements continue to strengthen competition and support innovation across the industry.
Conclusion
The global glaucoma surgery devices market is poised for steady expansion, growing from USD 1.55 billion in 2025 to USD 1.64 billion in 2026, and reaching USD 2.48 billion by 2034. Rising glaucoma prevalence, increasing adoption of minimally invasive glaucoma surgery (MIGS), and continuous technological advancements in implantable and laser-based devices are expected to drive long-term market growth. Although high procedural costs and shortages of trained ophthalmic surgeons remain challenges, ongoing innovation, favorable reimbursement developments, and expanding access to advanced eye care services will continue to support market expansion throughout the forecast period.
Segmentation By Device Type, Procedure Type, End-user, and Region
By Device Type * Glaucoma Drainage Devices
By Procedure Type * Traditional Surgery
By End-user * Hospitals & ASCs
By Region * North America (By Device Type, Procedure Type, End-user, and Country)